PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-Sep-2020 Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients Ampio Pharmaceuticals, Inc.
09-Sep-2020 PCR Biosystems launches RiboShield™ RNase Inhibitor to ensure reliable RNA protection PCR Biosystems
09-Sep-2020 American Skin Association Annual Gala Virtually Celebrates Outstanding Honorees American Skin Association
09-Sep-2020 Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaign for Women with Chronic Inflammatory Diseases UCB
09-Sep-2020 Proteros launches new cryo-EM facility to speed drug discovery Proteros Biostructures GmbH
08-Sep-2020 BERG's Study Provides Biological Insights Into The Increased Incidence Of COVID-19 In The African American Population BERG Health
08-Sep-2020 entrinsic bioscience Strengthens Leadership Team with Appointment of Mario Wanderley as Chief Financial Officer and Accelerates Product Development with New Research Facility entrinsic bioscience
08-Sep-2020 Neurocrine Biosciences to Present at the Morgan Stanley 18th Annual Global Healthcare Conference Neurocrine Biosciences, Inc.
08-Sep-2020 Celularity Doses First Patient in Clinical Trial Evaluating CYNK-001 in COVID-19 Patients Celularity, Inc.
08-Sep-2020 COVID-19 Causing Hidden Health Impacts Healint
08-Sep-2020 Hospital PMI(TM) at 63.8%; August 2020 Hospital ISM® Report On Business® Institute for Supply Management
08-Sep-2020 Sysmex Inostics' Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient Management Sysmex Inostics GmbH
08-Sep-2020 Liminal BioSciences Announces Resubmission of Biologics License Application to U.S. Food and Drug Administration for Ryplazim® (plasminogen) for Treatment of Congenital Plasminogen Deficiency Liminal BioSciences Inc.
08-Sep-2020 Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine Intravacc B.V.
08-Sep-2020 Mylan to Acquire Aspen's Thrombosis Business in Europe Mylan N.V.
07-Sep-2020 Farxiga demonstrated unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease in the Phase III DAPA-CKD trial AstraZeneca
07-Sep-2020 Signifier Medical Technologies appoints Philip Hess, former President & CEO of Bose Corporation, as Chief Operating Officer Signifier Medical Technologies
07-Sep-2020 Hansa Biopharma ger uppdatering om kliniska program Hansa Biopharma
07-Sep-2020 PAGE & PAGE AND PARTNERS ANNOUNCES: NEW PARTNERS, NEW LONDON OFFICE, CLIENTS WINS AND RECRUITMENT DRIVE DURING PANDEMIC Page & Page and Partners
07-Sep-2020 Coulter Partners secures Chief Financial Officer for Saniona Coulter Partners